Publicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (19)

2024

  1. Prognostic and survival factors in head and neck extra-nodal non-Hodgkin's lymphoma

    Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

2023

  1. A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

    Frontiers in Oncology, Vol. 13

  2. IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

    Journal of Fungi, Vol. 9, Núm. 6

  3. The implication of next-generation sequencing in the diagnosis and clinical management of non-Hodgkin lymphomas

    Frontiers in Oncology, Vol. 13

2022

  1. Immune Checkpoint Inhibitors in Acute Myeloid Leukemia: A Meta-Analysis

    Frontiers in Oncology, Vol. 12

  2. Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

    HemaSphere, Vol. 6, Núm. 4

  3. Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model

    HemaSphere, Vol. 6, Núm. 8

2021

  1. Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes

    PloS one, Vol. 16, Núm. 5, pp. e0248886

  2. Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

    PloS one, Vol. 16, Núm. 2, pp. e0247093

  3. Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models

    Frontiers in Oncology, Vol. 11

  4. Safety of FLT3 inhibitors in patients with acute myeloid leukemia

    Expert Review of Hematology, Vol. 14, Núm. 9, pp. 851-865

  5. Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data

    Leukemia, Vol. 35, Núm. 10, pp. 2924-2935

  6. The safety profile of FLT3 inhibitors in the treatment of newly diagnosed or relapsed/refractory acute myeloid leukemia

    Expert Opinion on Drug Safety, Vol. 20, Núm. 7, pp. 791-799

2020

  1. FLT3 inhibitors in the treatment of acute myeloid leukemia: Current status and future perspectives

    Minerva Medica, Vol. 111, Núm. 5, pp. 427-442

  2. Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling

    BMC Cancer, Vol. 20, Núm. 1

  3. Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia

    Journal of Oncology, Vol. 2019

  2. Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia

    Blood cancer journal

  3. New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data

    Frontiers in Genetics, Vol. 10